# Assistance Publique Hopitaux De Marseille

Organization · id `cardio:org-assistance-publique-hopitaux-de-marseille` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ROR record 002cp4060](<https://ror.org/002cp4060>), retrieved 18 November 2026. No person wrote or checked this page.

## In plain language

An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 7 trials in this atlas.

## Technical summary

Sponsor class other. Matched to ROR record 002cp4060 by an exact name.

## The registry's words

- Sponsor name: Assistance Publique Hopitaux De Marseille
- Sponsor class: OTHER
- ROR name: Assistance Publique Hôpitaux de Marseille

## Connected pages

- Sponsors: Impact of Clopidogrel Dose Adjustment According to Platelet Reactivity Monitoring in Patients With High on Treatment Platelet Reactivity Undergoing Percutaneous Coronary Intervention (`cardio:ct-nct01505790`)
- Sponsors: Evaluation of Ticagrelor Anti Platelet and Pleiotropic Effects in Patients Undergoing Percutaneous Coronary Intervention for an Acute Coronary Syndrome (`cardio:ct-nct01626534`)
- Sponsors: Prevention of Atrial Fibrillation Following Valvular Replacement With Cardiopulmonary Bypass: a Prospective, Randomized Clinical Study Comparing Oral Caffeine With Placebo (`cardio:ct-nct01999829`)
- Sponsors: Impact of Diffuse Myocardial Fibrosis on the Ventricular Function in Regurgitant Left-Sided Valve Heart Diseases ( The DIFFUsE Study) (`cardio:ct-nct02747485`)
- Sponsors: TicagRelor Or Clopidogrel in Severe and Terminal Chronic Kidney Disease Patients Undergoing PERcutaneous Coronary Intervention for an Acute Coronary Syndrome. (`cardio:ct-nct03357874`)
- Sponsors: Evaluation of the Efficacy of Early Implantation of a Percutaneous Left Ventricular Assist Devices in Acute Coronary Syndrome Complicated by Cardiogenic Shock Compared to Conventional Therapy: a Prospective, Multicenter, Randomized, Controlled and Open-label Clinical Trial (`cardio:ct-nct05366452`)
- Sponsors: Medical Monitoring of Older Adults Patients After Discharged From Heart Failure Hospitalization (`cardio:ct-nct06018532`)

## Provenance

Content hash: f69cb6701259e9092498244c400df660b3fc8b216e7f4a6d3302c461bb483c6f
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
